The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 22, No. 10, pp. 813-824.
© 1988 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Einarson, T.
Right arrow Articles by Koren, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Einarson, T.
Right arrow Articles by Koren, G


Research Articles

A method for meta-analysis of epidemiological studies

TR Einarson, JS Leeder, and G Koren

This article presents a stepwise approach for conducting a meta-analysis of epidemiological studies based on proposed guidelines. This systematic method is recommended for practitioners evaluating epidemiological studies in the literature to arrive at an overall quantitative estimate of the impact of a treatment. Bendectin is used as an illustrative example. Meta-analysts should establish a priori the purpose of the analysis and a complete protocol. This protocol should be adhered to, and all steps performed should be recorded in detail. To aid in developing such a protocol, we present methods the researcher can use to perform each of 22 steps in six major areas. The illustrative meta-analysis confirmed previous traditional narrative literature reviews that Bendectin is not related to teratogenic outcomes in humans. The overall summary odds ratio was 1.01 (chi 2 = 0.05, p = 0.815) with a 95 percent confidence interval of 0.66-1.55. When the studies were separated according to study type, the summary odds ratio for cohort studies was 0.95 with a 95 percent confidence interval of 0.62-1.45. For case-control studies, the summary odds ratio was 1.27 with a 95 percent confidence interval of 0.83-1.94. The corresponding chi-square values were not statistically significant at the p = 0.05 level.


This article has been cited by other articles:


Home page
Obstet GynecolHome page
H. A. Bennett, A. Einarson, A. Taddio, G. Koren, and T. R. Einarson
Prevalence of Depression During Pregnancy: Systematic Review
Obstet. Gynecol., April 1, 2004; 103(4): 698 - 709.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. L. Lanctot, N. Herrmann, K. K. Yau, L. R. Khan, B. A. Liu, M. M. LouLou, and T. R. Einarson
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
Can. Med. Assoc. J., September 16, 2003; 169(6): 557 - 564.
[Abstract] [Full Text]


Home page
NEJMHome page
G. Koren, A. Pastuszak, and S. Ito
Drugs in Pregnancy
N. Engl. J. Med., April 16, 1998; 338(16): 1128 - 1137.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1988 by Harvey Whitney Books Company.